From: Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study
Cycles (n = 256)
Patients (n = 50)
Methotrexate dose modification
35
13.7%
14
28%
BCNU dose modification
38
14.8%
Any dose modification
55
21.5%
18
36%
Cycle delay
22
8.6%
10
20%